Every year, the rapid increase in diseases leads to massive mortality rates underscoring the critical need for improved early detection methods. According to the World Health Organization (WHO), the majority of non-communicable disease (NCD) deaths, totaling 17.9 million annually, are attributed to cardiovascular diseases, followed by cancer, chronic respiratory diseases, and kidney disease. Emerging diagnostic… Continue reading Future of Healthcare: Innovations in Emerging Diagnostic Imaging Technology
Tag: diagnostic tests
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, will present new data and study results across its Precision Oncology and hereditary cancer platforms at the 2023 annual San Antonio Breast Cancer Symposium (SABCS). “Exact Sciences is looking forward to presenting new evidence at SABCS that adds important perspectives to treating breast… Continue reading Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy
Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, applauds the recently announced Centers for Medicare and Medicaid Services (CMS) Calendar Year 2023 Physician Fee Schedule proposal, which considers follow-up colonoscopy to an at-home test as a preventive service. If adopted, the rule would eliminate all cost to Medicare patients for a… Continue reading Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics, oncological research, and dry eye disease, announced that the Centers for Disease Control and Prevention (CDC) highlighted a study that the Company sponsored on neutralizing antibodies in its recent COVID-19 Science Update: Edition 116. Also Read:… Continue reading CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies